What information about the regulatory review period must be included in a patent term extension application?
A patent term extension application must include specific information about the regulatory review period as outlined in 37 CFR 1.740(a)(10). The required information varies depending on the type of product: For human drugs, antibiotics, and biological products: Effective date and number of the investigational new drug (IND) application Date and number of the new drug…
Read MoreWhat are the formal requirements for a patent term extension application?
The formal requirements for a patent term extension application are outlined in 37 CFR 1.740. Some key requirements include: Complete identification of the approved product Identification of the federal statute under which regulatory review occurred Date of product approval for commercial marketing or use For drug products, identification of each active ingredient Statement that the…
Read MoreHow should the marketing applicant’s activities be described in a patent term extension application?
The description of the marketing applicant’s activities is an important component of a patent term extension application. According to 37 CFR 1.740(a)(11), the application must include: “A brief description of the activities undertaken by the marketing applicant before the regulatory agency with respect to the approved product and the significant dates applicable to such activities.“…
Read MoreWhat information is required to demonstrate that a patent claims the approved product?
To demonstrate that a patent claims the approved product in a patent term extension application, 37 CFR 1.740(a)(9) requires the following: “The application need only explain how one product claim of the patent claims the approved product, if there is a claim to the product. In addition, the application need only explain how one method…
Read More